Table 5.

Univariate analysis of PFS and OS in relation to miRNA cutoff values.

PFS	No. Patients	No. Events	Median PFS (Months) (95% CI)	p	HR (95% CI)	p
hsa-miR-20b-5p
<1293	26	24	8.1 (5.0–12.5)		1.00
≥1293	26	20	14.0 (9.4–21.3)	0.008	0.44 (0.24–0.82)	0.010
hsa-miR-29b-3p
<3138	25	23	8.2 (5.0–12.4)		1.00
≥3138	27	21	14.9 (9.1–21.3)	0.021	0.50 (0.27–0.91)	0.024
hsa-miR-155-5p
<0.73	32	30	8.3 (6.1–9.7)		1.00
≥0.73	20	14	16.0 (10.2–23.0)	0.007	0.42 (0.22–0.81)	0.009
OS	No. Patients	No. Events	Median OS (Months) (95% CI)	p	HR (95% CI)	p
hsa-miR-20b-5p
<1293	26	23	11.6 (8.2–23.4)		1.00
≥1293	26	17	28.8 (19.3–42.9)	0.004	0.40 (0.21–0.77)	0.005
hsa-miR-29b-3p
<3138	25	22	15.5 (6.8–24.8)		1.00
≥3138	27	18	31.7 (13.9–47.1)	0.005	0.40 (0.21–0.78)	0.007
hsa-miR-155-5p
<0.73	32	27	13.5 (8.2–23.4)		1.00
≥0.73	20	13	31.6 (21.8–42.9)	0.024	0.47 (0.24–0.92)	0.028